
Clearside Biomedical Reports Q4 and Full Year 2024 Financial Results with Corporate Update
Recent Pharmaceutical Developments: CLS-AX in Wet AMD and ARCATUS ® in China In the dynamic world of pharmaceuticals, several significant developments have emerged recently, showcasing progress in various therapeutic areas. Two of these updates include the successful end-of-Phase 2 meeting with the Food and Drug Administration (FDA) for CLS-AX in Wet Age-Related Macular Degeneration (AMD)…